跳至主要内容
临床试验/NCT02666365
NCT02666365撤回4 期

Pharmacokinetic Comparison of Cefazolin Redosing Strategy for Surgical Prophylaxis. Bolus Dose vs Continuous Infusion

Milton S. Hershey Medical Center0 个研究点开始时间: 2018年3月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
撤回
主要终点
Difference in Area Under Curve (AUC) of Cefazolin plasma concentration and minimum inhibitory concentration (MIC) in both treatment arms

研究概览

简要总结

Patients undergoing an elective ventral hernia repair will be randomly assigned to receive either bolus infusion or continuous infusion of the cefazolin as the prophylactic antibiotic. The blood concentrations of unbound cefazolin would be measured in their blood samples and the levels compared within the two groups with respect to their minimal inhibitory concentration (MIC) value.

详细描述

Patients who will be undergoing elective ventral hernia repair will be potential candidates for this study. Once identified, the surgical team will approach the participant for consent and inclusion in the study. On the day of surgery, the subjects will be assigned to either the Bolus Group (CB) or Continuous Infusion Group (CI) according to a randomly generated assignment procedure. During the procedure, the dose of prophylactic Cefazolin will be given an hour before surgery and will be administered in accordance to group assignment. Subjects in the CB will receive bolus infusions of Cefazolin every 4 hours till the end of surgery. Subjects in the CI group will receive an initial bolus injection of Cefazolin followed by a continuous infusion till the closure of skin incision. Blood samples will be taken during surgery at t=0, 15, 30 and 60 minutes and every hour following till the end of surgery or 6 hours (whichever comes sooner)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age >18 years
  • •Elective open Ventral hernia repair in CDC class one (clean) cases
  • •Planned operative time greater than 4 Hours
  • •Planned routine administration of cefazolin for pre-op prophylaxis
  • •No history of MRSA

排除标准

  • •Patients unable to give informed consent
  • •Allergy to cephalosporins
  • •Pre-existing documented infection or ostomy (class II-IV wounds)
  • •Received cefazolin within 24 hours before surgery
  • •Creatinine clearance < 30 ml/min
  • •Upstaging of wound class intra-op that results in the administration of additional antibiotics

研究组 & 干预措施

Bolus infusion of Cefazolin

Active Comparator

Subjects undergoing a ventral hernia repair in this arm of the study will receive the surgical prophylactic, cefazolin, in a bolus infusion

干预措施: Bolus infusion of Cefazolin (Procedure)

Continuous Infusion of Cefazolin

Active Comparator

Subjects undergoing a ventral hernia repair in this arm of the study will receive the surgical prophylactic, cefazolin, in a continuous infusion

干预措施: Continuous infusion of Cefazolin (Procedure)

结局指标

主要结局

Difference in Area Under Curve (AUC) of Cefazolin plasma concentration and minimum inhibitory concentration (MIC) in both treatment arms

时间窗: First four hours

After blood sample collection is completed samples will be analyzed for plasma concentrations of cefazolin. This concentration will be compared with the standard minimum inhibitory concentration of Cefazolin. It is expected that the difference between AUC and MIC in the continuous infusion group will be higher than the bolus infusion group during the first four hours of surgery.

次要结局

  • Total dose of cefazolin administered during the first 24 hours(24 hours after the beginning of surgery)
  • Difference in AUC of plasma concentration between the two regimens for the entire duration of surgery(Duration of surgery)
  • Total dose of cefazolin administered during the surgery(Duration of surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kunal Karamchandani

Assistant Professor of Anesthesiology

Milton S. Hershey Medical Center

相似试验